Creating a Future for Cell and Gene Therapies in Asia-Pacific

Are cell and gene therapies important in the current or future treatment of your rare condition? Would you like to know more about how these “breakthrough” technologies work to deliver long-lasting and nearly “curative” benefits?  What are the most promising cell and gene therapies that may be available soon?   MOST IMPORTANTLY: how can we work together as a rare disease community to achieve access for patients in the Asia Pacific region?   APARDO began the conversation last fall. To continue, we invite you to 2 upcoming webinars in this series of "Building a pathway for access to gene and cell therapies across the Asia Pacific":

1. Gene and Cell Therapy: From Discovery to Delivery
2. Gene and Cell Therapy: Access, Equity and Funding

Join us as we look into the current landscape of gene and cell therapies, How can we go about implementing these therapies in health systems, and the advocacy role within.  With special guest speakers: Timothy D. Hunt, CEO of The Alliance for Regenerative Medicine (ARM), Josephine Lembong, PhD, Senior Manager, Science and Industry Affairs (ARM), Dr. Didu (Sandi) Kariyawasamn, Paedistric Neurologist and Researcher (UNSW Sydney), Julie Cini, Founder of Spinal Muscular Atrophy Australia

Register now for the Gene and Cell Therapy: Access, Equity and Funding Webinar: Register here